Please Wait...

Upcoming Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

Join us for our upcoming webinar on July 25th during which Sukrit Singh and Dr. Ayesha Hussain, both pharmacovigilance experts who are also Associate Directors of CRM at Bioclinica, Inc., will present and discuss case studies illustrating how market authorization holders and CROs are becoming partners of choice in the ever-changing world of pharmacovigilance outsourcing.

The need to comply with regulatory requirements is increasing with the demand for new therapies across the pharmaceutical industry, which is seeking newer, more efficient ways of managing the growing load of adverse event data. Outsourcing is becoming a possible solution for short or long-term needs for more companies because of the:

  • Unavailability of the necessary system components for timely pharmacovigilance implementation by first-time marketing authorization holders.
  • Need for larger companies to streamline processes and reduce wastage, for a more robust and compliant reporting system.

The presented case studies will provide examples of:

  • Streamlining and globalizing processes to increase compliance rates with regulatory agencies.
  • Increasing productivity and reducing time to market.
  • Focusing on data quality.
  • Employing business excellence strategies to identify more effective ways of presenting accurate and meaningful data.
  • Employing tools that help market authorization holders achieve ease of operation and better transparency.

To join us for this webinar and learn more, register here.

Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Our clients have substantial success w #eSource, some spanning well over a decade. Still other organizations remain… https://t.co/UwVs6ajPp4
bioclinica (9 hours ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still some in the industry remai… https://t.co/ASuUvN6xb9
bioclinica (2 days ago)
RT @RfwrightLSL: When Do You Think #BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In #Clinical #Research? https:…
bioclinica (5 days ago)
ICYMI: Our V.P./Head of Neuroscience & Cardiovascular Svcs., Dr. Joyce Suhy, talks about challenges in determining… https://t.co/Lns6B3VPPN
bioclinica (5 days ago)
RT @FCR_News_Today: FDA Issues New Guides on Use of Electronic Health Information in #ClinicalTrials. #ClinicalResearch https://t.co/j8LHV2…
bioclinica (2 weeks ago)
RT @MySCRS: @AcurianCaresT2D, @bioclinica, @Medidata, @GreenphireINC, @PAREXEL: these are just some of this year's Global Summit exhibitors…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen